Noncoding RNAs Regulating NF-κB Signaling.

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• Nuclear factor kappa B (NF-κB) is a transcription factor family vital for physiological and pathological processes.
• Constitutive activation of NF-κB is implicated in the development and progression of various malignant tumors.
• Dysregulated NF-κB activity in cancer involves complex molecular mechanisms.

Purpose of the Study:

• To discuss the regulatory roles of noncoding RNAs in NF-κB signaling within the context of malignant diseases.
• To highlight the involvement of microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) in modulating NF-κB pathways in cancer.

Main Methods:

• Review of existing literature on noncoding RNA regulation of NF-κB signaling in cancer.
• Analysis of molecular mechanisms underlying miRNA and lncRNA interactions with NF-κB components.
• Synthesis of current understanding of NF-κB pathway modulation by noncoding RNAs in oncogenesis.

Main Results:

• Noncoding RNAs, including miRNAs and lncRNAs, are key regulators of NF-κB pathway activity.
• These noncoding RNAs can act as either inhibitors or activators of NF-κB signaling depending on the specific cancer context.
• Dysregulation of miRNA and lncRNA expression contributes to aberrant NF-κB activation in tumors.

Conclusions:

• MicroRNAs and long noncoding RNAs represent critical regulatory nodes in the NF-κB signaling network in cancer.
• Targeting noncoding RNA-mediated regulation of NF-κB offers potential therapeutic strategies for malignant diseases.
• Further research into the intricate interplay between noncoding RNAs and NF-κB is essential for advancing cancer treatment.